B6.129(C)-Mir10atm1.1Ahl/Kctt

Status

Available to order

EMMA IDEM:08495
International strain nameB6.129(C)-Mir10atm1.1Ahl/Kctt
Alternative namemiR-10a KO
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolMir10atm1.1Ahl
Gene/Transgene symbolMir10a

Information from provider

ProviderAnders Lund
Provider affiliationPr. Anders Lund, Biotech Research and Innovation Centre, University of Copenhagen
Genetic informationA null allele of miR-10a was generated by gene targeting, consisting of the replacement of the 70 central nucleotides of the pre-miRNA sequence of miR-10a for a loxP-flanked neo selection cassette. Breeding of miR-10a +/neo mice to a mouse strain holding an ubiquitously expressed cre recombinase transgene resulted in deletion of the miR-10a genomic sequence and its replacement by a residual loxP site, yielding mice with the miR-10a +/- genotype. Mice carrying the miR-10a floxed allele (miR-10a +/-) were intercrossed with C57BL/6 mice for at least 7 generations before generating experimental cohorts.
Phenotypic informationHomozygous:
To extensively study miR-10a loss we generated a miR-10a knock out mouse. We showed that, in the Apc(min) mouse model of intestinal neoplasia, female miR-10a deficient mice develop significantly more adenomas than miR-10(+/+) and male controls. We further found that lactoperoxidase (Lpo) is extensively upregulated in the intestinal epithelium of mice deprived of miR-10a. Using in vitro assays, we demonstrate that the primary miR-10a target Kruppel-like factor 4 (Klf4) can upregulate transcription of Lpo, whereas siRNA knockdown of Klf4 reduces Lpo levels in HCT-116 cells. Furthermore, Klf4 is upregulated in the intestines of miR-10a knockout mice. Lpo has previously been shown to have the capacity to oxidize estrogens into potent depurinating mutagens, creating an unstable genomic environment that can cause initiation of cancer. Therefore, we postulate that Lpo upregulation in the intestinal epithelium of miR-10a deficient mice together with the predominant abundance of estrogens in female animals mainly accounts for the sex-related cancer phenotype we observed. This suggests that miR-10a could be used as a potent diagnostic marker for discovering groups of women that are at high risk of developing colorectal carcinoma, which today is one of the leading causes of cancer-related deaths.

Heterozygous:
Not investigated
Breeding historyIn parallel with intercross breedings of miR-10a +/- males to miR-10a +/- females to generate experimental cohorts, some miR-10a +/- males were backcrossed to C57BL/6 females to maintain the C57BL/6 purity of the strain (N=15).
References
  • Loss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female mice.;Stadthagen Gustavo, Tehler Disa, Høyland-Kroghsbo Nina Molin, Wen Jiayu, Krogh Anders, Jensen Klaus T, Santoni-Rugiu Eric, Engelholm Lars H, Lund Anders H, ;2013;PLoS genetics;9;e1003913; 24204315
Homozygous fertilenot known
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreKarolinska Institutet, Stockholm, Sweden
Animals used for archivingheterozygous 0, wild-type 0
Stage of embryos2-cell

Disease and phenotype information

MGI phenotypes (gene matching)
  • no abnormal phenotype detected / MGI
  • no phenotypic analysis / MGI
  • mortality/aging / MGI

Literature references

  • Loss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female mice.;Stadthagen Gustavo, Tehler Disa, Høyland-Kroghsbo Nina Molin, Wen Jiayu, Krogh Anders, Jensen Klaus T, Santoni-Rugiu Eric, Engelholm Lars H, Lund Anders H, ;2013;PLoS genetics;9;e1003913; 24204315

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).